As one of the most exciting yet controversial segments of the orthopedics market, the U.S. spinal implant market has seen rapid growth and increasing market size. Now, many manufacturers consider spinal implants a separate business division from traditional orthopedics. Following the decrease in 2020 caused by the COVID-19 pandemic, the U.S. spinal implant, and vertebral compression fracture (VCF) market has increased in value in recent years. After recovering from the impact of the pandemic, this market is to remain relatively flat over the forecast period.
While this market contains more than 30 significant competitors, six medical industry giants dominate the market. If you are interested in learning more about the competitive nature of this market and the top spinal implant manufacturers, keep on reading.
In 2020, Medtronic led the overall U.S. spinal implant and VCF market. Medtronic was the leader in the cervical fixation, interbody, and VCF segments. The company came in a very close second to DePuy Synthes in the TL fixation segment. Medtronic also held the second-leading position in the motion preservation segment and neuromonitoring segment. Medtronic’s leading position in the market will continually be challenged as new competitors in individual markets gradually erode the company’s share of the total market.
DePuy Synthes was the second-leading competitor in the U.S. spinal implant market. The company’s spine product portfolio contains several popular devices within the minimally invasive spinal implant industry. However, since selling its Prodisc® product line to Centinel Spine, the company has lost market share. Overall, DePuy Synthes was the leader in the thoracolumbar fixation segment and the second-leading competitor in the cervical fixation, and interbody segments.
Zimmer Biomet was the third-leading competitor in the U.S. spinal implant market in 2020. The company increased its market share after merging with Biomet in 2015 to form Zimmer Biomet Holdings. The company offers products for cervical fixation, thoracolumbar fixation, interbody, motion preservation, and electrical stimulation. The majority of sales generated in 2020 came from the Polaris™ thoracolumbar spinal system, as well as the Mobi-C® cervical disc.
Stryker was the fourth-leading competitor in the U.S. spinal implant market in 2020. The company was active in the cervical fixation, thoracolumbar fixation, interbody, and vertebral compression fracture markets. The company has grown since it acquired K2M at the end of 2018, adding new product lines and revenue streams to its portfolio. Stryker offers a competitive line of thoracolumbar fixation and interbody devices.
In 2020, Globus Medical was the fifth-leading competitor in the U.S. spinal implants market. The company was active in the cervical fixation, thoracolumbar fixation, interbody, and motion preservation markets. Globus has seen its strongest growth in the expandable interbody device segment with products such as the RISE®, MAGNIFY®, CALIBER®, and ALTERA®.
Lastly, NuVasive was the sixth-leading competitor in the U.S. spinal implant market. The company’s portfolio includes devices in cervical fixation, thoracolumbar fixation, interbody fixation, and motion preservation. The company has expanded its fixation portfolio over several years to accommodate both open and minimally invasive approaches, as well as hybrid procedures. As a result, Nuvasive saw its highest market share in cervical fixation and thoracolumbar fixation.
For more information on unit sales, average selling prices (ASPs), procedural volume, competitive analyses, and more, follow the link below to receive a free market synopsis for the U.S. spinal implant market. Additionally, iData offers a U.S. MIS spinal implant market report.